By Vaia Siapka (Gynaecologist – Reg. No. 030314546).
Patients undergoing egg donation treatment have an important physical advantage: the process is generally much easier than in vitro fertilisation (IVF) using their own eggs.
This is because they do not need to undergo ovarian stimulation or egg retrieval, as both procedures are carried out by the donor. Rather than stimulating her ovaries or undergoing egg collection, the patient receiving the embryo only needs to prepare her endometrium so that it is in the best possible condition at the time of transfer.
This is known as endometrial preparation for egg donation. It involves administering a combination of oestrogen and progesterone, alongside ultrasound monitoring to assess how the endometrium is responding. The treatment therefore involves fewer procedures and offers greater scheduling flexibility, although the protocol and timings must always be tailored to each patient.
Before embryo transfer, the endometrium must be prepared to ensure that the lining of the womb is in a suitable condition and, crucially, that the timing of transfer is synchronised with the embryo's stage of development.
There is no single protocol that suits every woman. For patients who still ovulate, preparation may be based on their natural menstrual cycle. In other cases, a hormone replacement or programmed cycle is used, with oestrogen and progesterone allowing more precise control over endometrial growth and transformation. In egg donation treatment, this type of hormonal preparation is particularly useful because it makes coordination between the recipient, donor and laboratory easier.
In a programmed cycle, the first stage of treatment usually involves taking estradiol, the main female sex hormone produced in the ovaries from testosterone. It can be administered in several ways, including oral tablets or transdermal patches, depending on the specialist's prescribed protocol.
Its purpose is to encourage the endometrium to grow, much as it does during the first half of a natural menstrual cycle. Some protocols also involve suppressing ovarian activity beforehand to achieve better control of the cycle, although not all patients need this step. Preparation is always personalised, taking into account the patient's age, ovarian function, menstrual pattern and the approach chosen by the medical team.
After several days of oestrogen treatment, a transvaginal ultrasound scan is performed to measure the thickness of the endometrium and assess its appearance.
A thickness of around 7 mm or more is commonly used as a reference point, although no single measurement guarantees implantation. In addition to thickness, the specialist may assess its ultrasound appearance, including the characteristic trilaminar (three-line) pattern seen during the proliferative phase.
If the response is satisfactory, treatment can move on to the next stage.

Once the endometrium is ready, progesterone treatment begins. This hormone transforms the lining that has grown in response to oestrogen and prepares it to receive the embryo. Progesterone may be administered vaginally, although other routes and combinations are used in certain protocols. Timing is particularly important at this stage: it is not simply a matter of giving progesterone, but of carefully matching the number of days the endometrium has been exposed to it with the developmental age of the embryo to be transferred.
For example, when a blastocyst is to be transferred, the team schedules the required number of days of progesterone exposure so that endometrial and embryonic development are synchronised. This is one of the most important aspects of treatment, because the endometrium is receptive for only a limited period. It is therefore essential to follow the clinic's instructions precisely about when to start each dose and not to change the schedule independently.
There is no exact number of days that applies to every patient. In many protocols, oestrogen is given for approximately 10–14 days before the first assessment of the endometrium, although this period may be extended or adjusted if necessary. Indeed, flexibility is one of the advantages of this approach.
Once progesterone has been started, however, scheduling becomes much stricter, because the day of embryo transfer must be matched to the hours or days of hormone exposure and the embryo's developmental stage.
So, although treatment as a whole may take several weeks, most of the process can be completed while maintaining a normal routine, with relatively few medical appointments.
The number of clinic visits required for monitoring is particularly important for international patients and those living far from one of IVF-Life's clinics in Spain.
Unlike IVF using a patient's own eggs, egg donation recipients do not need the frequent ultrasound scans required during ovarian stimulation, as there is no need to monitor multiple growing follicles or schedule egg retrieval. In most cases, one or two ultrasound scans are enough to confirm that the endometrium is responding appropriately, although the exact number varies from patient to patient.
If the endometrium has the expected characteristics at the first scan, progesterone can be scheduled to begin, followed by embryo transfer. If the lining is still thin, its appearance is unclear or another issue arises, oestrogen treatment may need to be extended and another scan arranged.
Because this treatment requires less monitoring than ovarian stimulation, some follow-up appointments can be arranged close to the patient's home, provided the ultrasound images and results can be shared with the medical team and the team considers this appropriate.
At IVF-Life, we regularly treat international patients. Our medical team is therefore experienced in planning treatment schedules in advance to minimise unnecessary travel and coordinate essential clinic visits with embryo transfer.
While the recipient's endometrium is being prepared, the laboratory must also coordinate the sperm that will be used to fertilise the donor's eggs. When sperm from the patient's partner is used, a semen analysis is usually carried out beforehand to assess parameters such as sperm concentration, motility and morphology.
The sample can then be collected at the clinic and processed in the laboratory using sperm preparation or capacitation techniques, which aim to select a suitable population of sperm for fertilisation. The eggs retrieved from the donor are then fertilised using the appropriate technique, which may be conventional IVF or intracytoplasmic sperm injection (ICSI), depending on the circumstances.
If donor sperm is used instead, the arrangements are different: the sample comes from a sperm bank and is selected according to the relevant medical, legal and compatibility criteria. In both cases, the laboratory coordinates fertilisation and embryo culture while the recipient's endometrium is prepared to receive the embryo.
Discover the laboratory stages:
IVF treatment with donor eggs, step by step.
Generally, no. Endometrial preparation mainly involves hormonal medication, so the recipient does not need ovarian stimulation injections or an egg retrieval procedure, two of the most physically demanding stages of IVF using one's own eggs.
Oestrogen can be taken as tablets or patches, while progesterone is often administered vaginally. As with any hormonal medication, side effects may occur, including breast tenderness, bloating, abdominal discomfort, vaginal discharge when progesterone is used locally, or mild mood changes. Their severity varies between patients.
Embryo transfer is not usually painful either. Some women describe discomfort similar to that experienced during a gynaecological examination, particularly when the speculum is inserted, but anaesthesia or sedation is not normally required.
Yes, in most cases. Endometrial preparation does not require bed rest or time off work, unless a particular medical circumstance means otherwise. Patients can therefore walk, work, drive and maintain their usual routine in the weeks leading up to transfer. Moreover, as there is no ovarian stimulation, the ovaries do not become enlarged as they do during conventional IVF. This means the same restrictions relating to vigorous exercise or the risk of ovarian torsion associated with stimulation do not apply.
The most important things at this stage are to take medication at the prescribed times and attend scheduled monitoring appointments.
Madero S, Rodriguez A, Vassena R, Vernaeve V.
Endometrial preparation: effect of estrogen dose and administration route on reproductive outcomes in oocyte donation cycles with fresh embryo transfer.
.
2016;
1755-1764
Estudio sobre el efecto de la dosis y la vía de administración de estrógenos en los resultados reproductivos de ciclos de ovodonación con transferencia embrionaria en fresco:
https://pubmed.ncbi.nlm.nih.gov/27141040/
Younis JS, Simon A, Laufer N.
Endometrial preparation: lessons from oocyte donation.
.
1996;
873-884
Revisión científica sobre la preparación endometrial mediante estrógenos y progesterona en tratamientos de ovodonación y su influencia en la receptividad del endometrio:
https://pubmed.ncbi.nlm.nih.gov/8941049/
Arce H, Velilla E, López-Teijón M.
Association between endometrial thickness in oocyte donation cycles and pregnancy success rates.
.
2016;
1288-1294
Estudio que analiza la relación entre el grosor endometrial y las tasas de embarazo en ciclos de ovodonación, evaluando su utilidad como indicador del éxito reproductivo:
https://pubmed.ncbi.nlm.nih.gov/25707405/
Check JH, Nowroozi K, Choe J, Dietterich C.
Endometrial thickness is predictive of histologic endometrial maturation in women undergoing hormone replacement for ovum donation.
.
1996;
380-383
Investigación sobre la relación entre el grosor endometrial y la maduración histológica del endometrio en mujeres que reciben tratamiento hormonal para ovodonación:
https://pubmed.ncbi.nlm.nih.gov/8751733/
Remohí J, Gutiérrez A, Cano F, Ruiz A, Simón C, Pellicer A.
Long oestradiol replacement in an oocyte donation programme.
.
1995;
1387-1391
Estudio sobre los efectos de prolongar la administración de estradiol durante la preparación endometrial en receptoras de ovocitos y su relación con la implantación embrionaria:
https://pubmed.ncbi.nlm.nih.gov/7593502/
Borini A, Dal Prato L, Bianchi L, Violini F, Cattoli M, Flamigni C.
Effect of duration of estradiol replacement on the outcome of oocyte donation.
.
2001;
185-190
Investigación sobre la influencia de la duración del tratamiento con estradiol en la receptividad endometrial y los resultados de embarazo en ciclos de donación de ovocitos:
https://pubmed.ncbi.nlm.nih.gov/11432108/
Michalas S, Loutradis D, Drakakis P, Kallianidis K, Milingos S, Deligeoroglou E.
A flexible protocol for the induction of recipient endometrial cycles in an oocyte donation programme.
.
1996;
1063-1066
Estudio que evalúa un protocolo flexible de preparación endometrial con estrógenos y progesterona para coordinar la transferencia embrionaria en tratamientos de ovodonación:
https://pubmed.ncbi.nlm.nih.gov/8671391/
Gursu T, Goksever Celik H, Eraslan A, Angun B, Ozaltin S, Yeh J.
Impact of endometrial thickness change in response to progesterone on live birth rates embryo transfers with fresh oocyte donation cycles.
.
2022;
3260-3267
Estudio sobre los cambios en el grosor endometrial tras la administración de progesterona y su posible relación con las tasas de nacido vivo en ciclos de ovodonación:
https://pubmed.ncbi.nlm.nih.gov/35983690/
American Society for Reproductive Medicine (ASRM).
Gamete and embryo donation guidance.
.
2024;
799-813
Guía clínica de la ASRM que recoge recomendaciones sobre la selección y evaluación de donantes, los criterios médicos y genéticos y la seguridad de los procedimientos de donación de gametos y embriones:
https://www.asrm.org/practice-guidance/practice-committee-documents/guidance-regarding-gamete-and-embryo-donation/